Anixa Biosciences (ANIX) Debt Ratio (2010 - 2017)

Anixa Biosciences' (ANIX) quarterly Debt Ratio came in at 0.24 in Q3 2017, down 42.56% on a QoQ basis from 0.41 in Q2 2017.

Anixa Biosciences (ANIX) Debt Ratio (2010 - 2017) Analysis & Trends

Anixa Biosciences (ANIX) has 6 years of Debt Ratio data on file, last reported at 0.24 in Q3 2017.

Quarterly Debt Ratio changed N/A year-over-year to 0.24 in Q3 2017, while the trailing twelve-month figure through Jul 2017 was 0.24 (changed N/A YoY) and the FY2013 annual result came in at 0.92, up 4.07% from the prior year.
Debt Ratio retreated to 0.24 in Q3 2017, from 0.41 in the prior quarter.
In the past five years, Debt Ratio ranged from a high of 1.42 in Q1 2017 to a low of 0.24 in Q3 2017.
A 3-year average of 0.66 and a median of 0.57 in 2013 frame the typical range for Debt Ratio.
Annual changes were most pronounced in 2013 — Debt Ratio advanced 10.92% — and 2014, when it tumbled 60.39%.
Tracing ANIX's Debt Ratio over 3 years: stood at 0.92 in 2013, then tumbled by 59.4% to 0.37 in 2014, then plunged by 36.3% to 0.24 in 2017.
The last three Debt Ratio figures came in at 0.24 (Q3 2017), 0.41 (Q2 2017), and 1.42 (Q1 2017), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	0.05
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	0.05
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	0.12
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	0.03
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	0.26
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	0.47
10	Anixa Biosciences	123.62 Mn	123.62 Mn	-	-

Download Data